Cannabis inhaler: medical trials now underway
Israel-based Panaxia Pharmaceutical Industries is collaborating with another Israeli pharmaceutical business, Rafa, in performing a medical research in the utilization of medical cannabis concentrates for breathing. This brand brand new distribution method aims to improve accessibility for cancer tumors patients whom are addressed with long-lasting pharmaceutical cannabis like sublingual pills and for those people who are struggling with severe cancer tumors discomfort but choose in order to avoid cigarette smoking pot.
Panaxia announced the clinical test for enrollment purposes at Israel’s Ministry of wellness. The test will examine the availability that is biological of delivering medical cannabis via metered-dose inhaler.
The cannabis inhaler includes an attached vaporizer, where in fact the client will add the calculated dosage of cannabis extract to be inhaled.Read More